Insights

What is Your Data Integration and Analytics Platform Strategy?

If I Could Only Ask Two Questions, the First One Would Be: What is Your Data Integration and Analytics Platform Strategy? It’s really simple, data analytics drives decisions. In the healthcare industry, we use data to…

A Patient Hero

Articles

PharmaVOICE Precision Medicine Showcase

Improving Patient Adherence With Behavioral Health Technology The industry’s shift to outcomes-based, patient-centered care requires new approaches to patient support to achieve adherence and therapeutic success. Today’s patients are also highly motivated information seekers and are…

PharmaVOICE Connected Health Showcase

IF I COULD ONLY ASK TWO QUESTIONS, THE FIRST WOULD BE: What is your data integration and analytics platform strategy? As the industry continues its shift to a patient-centric, value-based model of care, it is critical…

PharmaVOICE Showcase on Connected Health and IoT

The Growing Potential of Connected IoT In PharmaVOICE’s Showcase on Connected Health and IoT, Ed Cox offers executive viewpoints on the challenges of integrating the Internet of Medical Things (IoMT) into pharma processes. “Breaking down siloes…

PharmaVOICE Rare Disease Showcase

Why should pharmaceutical manufacturers in the rare disease space channel and communicate their inner WHY to patients? Because it’s how we can improve the adherence rate of orphan drugs from a low 60%, which the industry…

Improving Patient Adherence with Behavioral Health Technology

The industry’s shift to outcomes-based, patient-centered care requires new approaches to patient support to achieve adherence and therapeutic success. Today’s patients are also highly motivated information seekers and are taking control of their day-to-day therapy. And,…

New Product Commercialization – Webinar

Q. How do you successfully commercialize a new product in the new era of “patient-as-consumer” and “outcomes-based healthcare”? A. You design and deliver an engaging, high-touch patient experience. In this 30 minute webinar, Tom Doyle explains…

The Role of Chief Patient Officers

A Seat of Influence. Patients rely on us not only to develop life-saving therapies, but also for help in developing strategies to ensure that they can access those therapies. The role of the Chief Patient Officer…

How the “Power of Why” Can Improve Adherence Rates in Rare Disease

“There are only two ways to influence human behavior: you can manipulate it or you can inspire it.” — Simon Sinek, Author of Start With Why Best-selling author and motivational speaker, Simon Sinek, is best known…

Improving the Impact of an Oncology Patient Access Program

Our client, a specialty pharmaceutical company focused on the research and development of new therapies in two high-cost complex drug categories, sought to benchmark its patient assistance program against those of its competitors in order to…

Strategies to Ensure Market Success of a Rare Disease Product Launch

Small patient populations, complex administration, high costs of therapies, and government policy interventions are just a few obstacles in rare disease. EVERSANA’s Managing Director, Bill O’Bryon, and Senior Director, Diann Johnson, outline key insights to consider…